DEO vs SAM: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

DEO is the larger of the two ($54.79B market cap): the incumbent the market prices for continued execution (13.98x forward earnings, beta 0.37). SAM is the smaller challenger ($2.13B), actually pricier on forward earnings (20.36x): more room to run, but more to prove. If you believe SAM earns its premium (20.36x forward earnings, so the market expects more from it), SAM fits. If you believe in paying less for profit, DEO fits at 13.98x.

DEO vs SAM: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricDEOSAMWhat it tells you
Market cap$54.79B$2.13BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E13.9820.36Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Beta0.370.80Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range86% of range49% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book90.692.85How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: DEO is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how DEO and SAM affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. DEO and SAM share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined DEO and SAM exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Diageo (DEO) do?

Diageo plc is the largest spirits producer in the world by value, selling in roughly 180 markets from a portfolio that spans Johnnie Walker, Buchanan's and other Scotch, Smirnoff and Ketel One vodka, Tanqueray and Gordon's gin, Captain Morgan rum, Crown Royal Canadian whisky, Bulleit bourbon, Baileys, the Don Julio and Casamigos tequilas, and Guinness stout. It also holds controlling stakes in listed subsidiaries including United Spirits in India, and has been reshaping the edges of the group: East Africa Breweries is being sold with completion expected in calendar H2 2026, and United Spirits is divesting the Royal Challengers Bengaluru cricket franchise. The economics are those of a branded-goods owner rather than a manufacturer, with pricing power, long aging cycles for whisky and tequila that tie up working capital, and distribution scale that is hard to replicate.

Full DEO guide

What does The Boston Beer Company (SAM) do?

The Boston Beer Company, founded by Jim Koch in 1984, is one of the largest US-owned beverage alcohol makers. It built its name on Samuel Adams Boston Lager, then diversified into what the industry calls "beyond beer": Twisted Tea hard iced tea (now its biggest brand), Truly hard seltzer, Angry Orchard cider, Dogfish Head craft beer and spirits, and Sun Cruiser, a vodka-based iced tea and lemonade cocktail launched in 2024. It sells through a three-tier network of independent distributors, brews mostly in company-owned breweries plus contract partners, and is controlled by Koch through Class B shares that elect most of the board. Koch returned as CEO in August 2025, and on November 19, 2026 the board named Chief Operating Officer Phil Hodges President and CEO effective November 23, 2026, with Koch staying on as Founder, Brewer and Executive Chairman.

Full SAM guide

DEO vs SAM: how do they differ?

Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.

  • DEO drivers: The cost program and margin defence; Deleveraging and the reset dividend.
  • SAM drivers: Sun Cruiser and the spirits-based cocktail shift; Gross margin recovery from the supply chain overhaul.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The core risk is that the spirits downturn is structural rather than cyclical: US consumption has been falling since the post-pandemic peak, and moderation trends among younger drinkers, GLP-1 weight-loss drugs and cannabis substitution are all cited as reasons the volume base may not recover to prior trend. For SAM, volume is the central risk: depletions are down ~5% year to date in 2026 after several down years, and US beer and seltzer demand faces younger consumers drinking less, GLP-1 weight-loss drugs, cannabis beverages and non-alcoholic options.

DEO or SAM: which should you pick?

If the story you believe is DEO's (The cost program and margin defence), DEO is the more direct way to own it; if it is SAM's (Sun Cruiser and the spirits-based cocktail shift), SAM is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the DEO and SAM guides.

DEO vs SAM: the full fundamentals

DEO. At roughly $98 per ADR, DEO trades near ~14x forward earnings and about ~15x fiscal 2026 earnings before exceptional items (~$6.61 per ADR), well below the 20x-plus multiple of the 2010s. The trailing P/E of ~31x is inflated by ~$1.5 billion of impairments and ~$0.9 billion of restructuring that cut reported EPS to ~$3.12 per ADR. Yahoo Finance now shows a yield of ~2.0% on the reset ~$2.00 per ADR dividend, and company-basis free cash flow was ~$3.2 billion in fiscal 2026.

SAM. Trailing GAAP earnings are a loss because of the ~$194.5M litigation charge booked in 2026, so the useful yardstick is non-GAAP guidance: at ~$211 the shares trade at roughly 20 to 23 times the 2026 range of $9.00 to $10.50, and ~20 times the ~$10.33 analysts expect for 2027. Net of cash, enterprise value is ~$1.8B, about 1.0 times trailing revenue, though the unpaid judgment would lift that if paid. The multiple rests on margin recovery, ~$351M of trailing free cash flow and buybacks more than top-line growth, and if volumes keep falling, margin gains alone may not sustain it.

Headline figures (approximate, November 2026): DEO shows net sales (fy2026, ttm) ~$19.6B, -3.0% reported, -2.0% organic, operating profit (before exceptionals) ~$5.7B, ~28.9% margin, net income (ttm, reported) ~$1.74B, ~8.8% net margin, eps per adr (trailing / fy2027 consensus) ~$3.12 reported / ~$6.69; SAM shows revenue (ttm) ~$1.91B (Q3 2026 down 3.2%), gross / operating margin (ttm) ~49.1% / ~5.6%, net income (ttm) ~-$73M GAAP loss (litigation charge), q3 2026 non-gaap eps ~$4.37 vs ~$4.21 consensus.

The bottom line: DEO vs SAM

DEO and SAM are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined DEO and SAM exposure against your real portfolio. It is not an investment adviser.

Wondering how DEO or SAM fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Diageo

Ask Walnut's AI anything about DEO and see how it fits what you own.

FAQ

What is the difference between DEO and SAM?

+

Diageo plc is the largest spirits producer in the world by value, selling in roughly 180 markets from a portfolio that spans Johnnie Walker, Buchanan's and other Scotch, Smirnoff and Ketel One vodka, Tanqueray and Gordon's gin, Captain Morgan rum, Crown Royal Canadian whisky, Bulleit bourbon, Baileys, the Don Julio and Casamigos tequilas, and Guinness stout. The Boston Beer Company, founded by Jim Koch in 1984, is one of the largest US-owned beverage alcohol makers. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is DEO or SAM the better stock?

+

Neither is universally better. DEO is the larger incumbent; SAM is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, DEO or SAM?

+

On forward P/E (as of November 2026), DEO trades at 13.98x and SAM at 20.36x, so DEO is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both DEO and SAM?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of DEO vs SAM?

+

DEO: The core risk is that the spirits downturn is structural rather than cyclical: US consumption has been falling since the post-pandemic peak, and moderation trends among younger drinkers, GLP-1 weight-loss drugs and cannabis substitution are all cited as reasons the volume base may not recover to prior trend. Leverage at ~3.1x limits flexibility, and the ~$1.5 billion of fiscal 2026 impairments (largely Turkiye hyperinflation accounting plus the Don Papa writedown) shows how quickly acquired brand value can be marked down. Tariffs of roughly $200 million a year are a live cost that depends on trade policy Diageo does not control, and the aged inventory model means production decisions made years ago cannot be reversed if demand shifts. Currency translation matters too, since Diageo reports in US dollars but earns across dozens of currencies, and the ADR adds depositary fees on top. There is also open consumer litigation over the labelling of Casamigos and Don Julio as 100% blue weber agave, pending in the Eastern District of New York, and a new chief executive's cost program of this size carries its own execution risk on brand investment and talent. With the ADR up ~12.9% in 2026 and near the top half of its 52-week range, the valuation also leaves less room for a disappointing first-half update than it did at the lows. SAM: Volume is the central risk: depletions are down ~5% year to date in 2026 after several down years, and US beer and seltzer demand faces younger consumers drinking less, GLP-1 weight-loss drugs, cannabis beverages and non-alcoholic options. The Ardagh Metal Packaging judgment (~$175.5M plus ~$15.5M of pre-judgment interest, now accruing post-judgment interest at ~3.79%) remains under post-trial motions and appeal; the company has cash to cover it, but paying it would absorb most of its cash balance. Aluminum, freight and tariff costs are volatile (2026 tariff costs are guided at $18M to $22M), and freight alone added ~$20.6M of selling expense year to date. Leadership is in transition: an interim CFO is in place, and Phil Hodges, a supply chain and operations executive who joined as a consultant in 2022, becomes CEO on November 23, 2026 with no prior record running the brands or marketing side. The dual-class structure gives Jim Koch effective control, limiting outside shareholder influence. Finally, the stock trades a small float with large daily swings (it rose ~10% on November 2, 2026 alone), and its ~$211 price (November 20) sits within a wide ~$159 to ~$264 52-week range. Tougher state rules on spirits-based RTDs or higher excise taxes could also slow Sun Cruiser's rollout.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell DEO or SAM; figures are approximate and dated (as of November 2026). Verify current data before investing.